Gonorrhea and syphilis in incarcerated urban adolescents: prevalence and physical signs. NLM AIDSLINE Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Gonorrhea and syphilis in incarcerated urban adolescents: prevalence and physical signs.

Pediatrics. 1987 Oct;80(4):561-4. Unique Identifier : AIDSLINE MED/88015390
Alexander-Rodriguez T; Vermund SH; Spofford Juvenile Health Services, Montefiore Medical Center,; Bronx, NY 10467.

Abstract: During a 1-year period from July 1983 to June 1984, 285 adolescent girls and 2,236 adolescent boys, ranging in age from 9 to 18 years (89% were 14 to 16 years of age), were screened for gonorrhea and syphilis on entry into a detention facility in New York City. The prevalence rate for gonorrhea was 3% for boys and 18.3% for girls, and the prevalence rate for syphilis was 0.63% for boys and 2.5% for girls. The rates of gonorrhea without penile or cervical discharge on physical examination were 2.1% for boys and 10.9% for girls. This high prevalence of syphilis and gonorrhea and the high frequency of disease without physical signs of illness indicate the desirability of screening high-risk adolescents for these and other sexually transmitted diseases. Our data support the need for programs in detention facilities and, we believe, schools, to encourage use of barrier contraceptives to control gonorrhea, syphilis, Chlamydia, human papillomavirus, human immunodeficiency virus, and unwanted pregnancy.
Keywords: Adolescence Age Factors Child Female Gonorrhea/DIAGNOSIS/*EPIDEMIOLOGY Human Male New York City *Prisoners Retrospective Studies Sex Factors Syphilis/DIAGNOSIS/*EPIDEMIOLOGY Urban Health JOURNAL ARTICLE

KWDadolescenceagefactorschildfemalegonorrhea/diagnosis/KWDepidemiologyhumanmalenewyorkcityKWDprisonersretrospectivestudiessexfactorssyphilis/diagnosis/KWDepidemiologyurbanhealthjournalarticle
880130
M8810300

Copyright © 1988 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .